当前位置:首页 - 行情中心 - 颖泰生物(920819) - 财务分析 - 现金流量表

颖泰生物

(920819)

  

流通市值:39.62亿  总市值:40.08亿
流通股本:12.12亿   总股本:12.26亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,077,683,127.314,079,930,922.792,995,892,498.932,020,307,381.89
  收到的税费返还59,718,961.7258,554,565.75208,138,076.85130,219,005.92
  收到其他与经营活动有关的现金58,907,459.59102,359,785.7657,009,660.7531,701,815.65
  经营活动现金流入小计1,196,309,548.64,440,845,274.33,261,040,236.532,182,228,203.46
  购买商品、接受劳务支付的现金798,256,916.372,770,561,616.042,272,915,209.441,399,070,218.78
  支付给职工以及为职工支付的现金196,543,959.38657,950,188.96503,742,692.79352,952,905
  支付的各项税费44,124,419.01141,705,637.09110,447,062.3183,625,731.87
  支付其他与经营活动有关的现金54,369,575.23271,639,383.01180,288,315.05123,890,887.77
  经营活动现金流出小计1,093,294,869.993,841,856,825.13,067,393,279.591,959,539,743.42
  经营活动产生的现金流量净额103,014,678.61598,988,449.2193,646,956.94222,688,460.04
二、投资活动产生的现金流量:
  收回投资收到的现金64,832,000115,580,00070,000,00070,000,000
  取得投资收益收到的现金5,508,144.1835,541,595.3621,137,967.215,573,668.5
  处置固定资产、无形资产和其他长期资产收回的现金净额111,078.2225,025,006.8423,332,803.8417,036,197.1
  投资活动现金流入小计70,451,222.4176,146,602.2114,470,771.04102,609,865.6
  购建固定资产、无形资产和其他长期资产支付的现金54,503,775.93163,529,075.74141,659,531.9693,458,652.36
  投资支付的现金-99,000,000--
  支付其他与投资活动有关的现金-282,450242,000242,000
  投资活动现金流出小计54,503,775.93262,811,525.74141,901,531.9693,700,652.36
  投资活动产生的现金流量净额15,947,446.47-86,664,923.54-27,430,760.928,909,213.24
三、筹资活动产生的现金流量:
  取得借款收到的现金718,042,578.884,660,729,985.443,880,081,175.011,960,726,124.57
  收到其他与筹资活动有关的现金10,287,208.9418,595,234.6370,185,620.8910,843,281.46
  筹资活动现金流入小计728,329,787.824,679,325,220.073,950,266,795.91,971,569,406.03
  偿还债务支付的现金798,071,571.234,823,832,428.373,836,691,523.822,011,627,711.67
  分配股利、利润或偿付利息支付的现金36,842,438.78175,736,115.5127,014,207.6181,744,306.08
  其中:子公司支付给少数股东的股利、利润-3,780,0003,780,0003,780,000
  支付其他与筹资活动有关的现金5,879,492.04105,661,543.87198,623,385.19147,028,382.95
  筹资活动现金流出小计840,793,502.055,105,230,087.744,162,329,116.622,240,400,400.7
  筹资活动产生的现金流量净额-112,463,714.23-425,904,867.67-212,062,320.72-268,830,994.67
四、汇率变动对现金及现金等价物的影响-5,104,944.286,196,484.868,140,819.217,303,518.75
五、现金及现金等价物净增加额1,393,466.5792,615,142.85-37,705,305.49-29,929,802.64
  加:期初现金及现金等价物余额621,472,058.86528,856,916.01528,856,916.01528,856,916.01
  期末现金及现金等价物余额622,865,525.43621,472,058.86491,151,610.52498,927,113.37
补充资料:
  净利润--260,398,538.1-12,962,119.77
  资产减值准备-95,483,872.25--
  固定资产和投资性房地产折旧-436,870,869.58-224,374,236.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-436,870,869.58-224,374,236.01
  无形资产摊销-40,731,784.01--
  长期待摊费用摊销-5,840,120.71-4,676,919.32
  处置固定资产、无形资产和其他长期资产的损失--13,433,851.23--11,784,053.1
  固定资产报废损失-2,823,314-2,477,114.29
  公允价值变动损失-1,370.4--1,178,100.54
  财务费用-149,960,419.26-68,462,687.92
  投资损失-61,730,501.82--20,751,086.12
  递延所得税--52,606,012.36--12,872,437.54
  其中:递延所得税资产减少--50,558,128.34--10,811,088.84
    递延所得税负债增加--2,047,884.02--2,061,348.7
  存货的减少-175,919,720.41-82,257,883.44
  经营性应收项目的减少--85,358,560.11-1,132,942.63
  经营性应付项目的增加--3,471,739.46--156,668,821.1
  其他-174,981.28--
  现金的期末余额-621,472,058.86-498,927,113.37
  减:现金的期初余额-528,856,916.01-884,664,117.62
  现金及现金等价物的净增加额-92,615,142.85--385,737,004.25
公告日期2026-04-242026-04-162025-10-242025-08-15
审计意见(境内)标准无保留意见
TOP↑